Dipeptidyl Peptidase IV as a Prognostic Marker and Therapeutic Target in Papillary Thyroid Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dipeptidyl Peptidase IV as a Prognostic Marker and Therapeutic Target in Papillary Thyroid Carcinoma

Published:2017-05-26 Issue:8 Volume:102 Page:2930-2940
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Lee Jie-Jen,Wang Tao-Yeuan,Liu Chien-Liang,Chien Ming-Nan,Chen Ming-Jen,Hsu Yi-Chiung,Leung Ching-Hsiang,Cheng Shih-Ping

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/102/8/2930/19452725/jc.2017-00346.pdf

Reference40 articles.

1. The dipeptidyl peptidase IV family in cancer and cell biology;FEBS J,2010

2. Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus;Nat Rev Endocrinol,2016

3. Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors;Endocr Rev,2014

4. Thyroid cancer mortality and incidence: a global overview;Int J Cancer,2015

5. Biologic and clinical perspectives on thyroid cancer;N Engl J Med,2016

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ferroptosis in thyroid cancer: Potential mechanisms, effective therapeutic targets and predictive biomarker;Biomedicine & Pharmacotherapy;2024-08

2. Estrogen-mediated DNMT1 and DNMT3A recruitment by EZH2 silences miR-570-3p that contributes to papillary thyroid malignancy through DPP4;Clinical Epigenetics;2024-06-18

3. Role of SGLT2 Inhibitors, DPP-4 Inhibitors, and Metformin in Pancreatic Cancer Prevention;Cancers;2024-03-28

4. Exploring the clinical utility of DPP-IV and SGLT2 inhibitors in papillary thyroid cancer: a literature review;Frontiers in Pharmacology;2024-01-16

5. m6A reader IGF2BP2 promotes lymphatic metastasis by stabilizing DPP4 in papillary thyroid carcinoma;Cancer Gene Therapy;2023-12-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3